This is research, not a buy or sell recommendation. Robo-advice in Taiwan requires an FSC licence; FEAF analyses, explains and monitors, and the investor makes the decision. Judgement thresholds are working rules pending review by the team's finance members.
Plain-language summary of valuation, growth, profitability, balance sheet, and recent MOPS filings.
For a moderate profile, none of the items above crosses the watch-out thresholds set by the team.
In plain words
Stock 1717 has a P/E ratio of 31.95, which is well above the Chemicals median of 18.46 across 26 listed peers, indicating it is priced richer than its peers. The company recorded one verified alert on 2026-11-12 regarding the board approval of its Q3 2026 consolidated financial report, while one filing is held or rejected awaiting human review. Overall, the reviewed data shows no strong signal either way, and none of the items cross watch-out thresholds for a moderate profile. Ultimately, the final investment decision rests entirely with the investor.
Written by gemini-3.6-flash from the facts above; every number was checked against them.
Strengths
——
Watch-outs
!P/E 31.95 is well above the Chemicals median of 18.46 (26 listed peers): priced richer than peers. source (Key Stats) →
What to check before deciding
?Why is it priced above its peers, and is that premium justified?
What the analysis found
!Valuation vs peersP/E 31.95 is well above the Chemicals median of 18.46 (26 listed peers): priced richer than peers. source →
·Filings1 verified alert(s); latest on 2026-11-12: 公告本公司115年第3季合併財務報告業經董事會決議通過 source →
·Filings1 filing(s) are held or rejected and wait for human review. source →